PI/Clinical Negligence: Critical condition
The NHSLA's effective monopoly of the defendant clinical negligence market has led to questions over its relations with panel firms. Sophie Evans looks at the system as another NHSLA panel review looms
Six years ago, there were approximately 90 firms defending the NHS against patient claims of clinical negligence. Since the National Health Service Litigation Authority (NHSLA) was created in 1998, this figure has been slashed to just 14, as the authority centralised control of the previously fragmented claims management system. Uniquely in the litigation world, firms sitting on the NHSLA panel have only one choice of client – and if the constant screwing down on costs makes partner profits suffer, they have to like it or lump it.
This premium content is reserved for
Legal Week Subscribers.
Subscribe today and get 10% off.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Unique access to ALM's unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week's UK Top 50 and Global 100 rankings
- The Legal Week Daily News Alert, Editor's Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now
For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651